Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in Cameroon
C Kouanfack, C Laurent, G Peytavin… - JAIDS Journal of …, 2008 - journals.lww.com
Objectives: To compare adherence to antiretroviral therapy using drug level monitoring and
self-report and to explore the relation between these 2 methods and viral load
measurements. Methods: Sixty patients received a fixed-dose combination of nevirapine,
stavudine, and lamivudine in a clinical study in Cameroon. Adherence was assessed every
6 months until month 36 by nevirapine minimal plasma concentration and self-report.
Plasma HIV-1 viral load was determined at the same time. Analyses included 159 complete …
self-report and to explore the relation between these 2 methods and viral load
measurements. Methods: Sixty patients received a fixed-dose combination of nevirapine,
stavudine, and lamivudine in a clinical study in Cameroon. Adherence was assessed every
6 months until month 36 by nevirapine minimal plasma concentration and self-report.
Plasma HIV-1 viral load was determined at the same time. Analyses included 159 complete …
Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon
G Peytavin, M Ngolle, YM Nkene… - Journal of Acquired …, 2008 - scienceportal.msf.org
OBJECTIVES: To compare adherence to antiretroviral therapy using drug level monitoring
and self-report and to explore the relation between these 2 methods and viral load
measurements. METHODS: Sixty patients received a fixed-dose combination of nevirapine,
stavudine, and lamivudine in a clinical study in Cameroon. Adherence was assessed every
6 months until month 36 by nevirapine minimal plasma concentration and self-report.
Plasma HIV-1 viral load was determined at the same time. Analyses included 159 complete …
and self-report and to explore the relation between these 2 methods and viral load
measurements. METHODS: Sixty patients received a fixed-dose combination of nevirapine,
stavudine, and lamivudine in a clinical study in Cameroon. Adherence was assessed every
6 months until month 36 by nevirapine minimal plasma concentration and self-report.
Plasma HIV-1 viral load was determined at the same time. Analyses included 159 complete …
以上显示的是最相近的搜索结果。 查看全部搜索结果